Pages that link to "Q70511187"
Jump to navigation
Jump to search
The following pages link to Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases (Q70511187):
Displaying 50 items.
- Point: Chronic Activation of the Sympathetic Nervous System is the Dominant Contributor to Systemic Hypertension (Q22306470) (← links)
- New drugs in hypertension (Q24680276) (← links)
- Oral renin inhibitors (Q28269879) (← links)
- Effect of diuretic, beta-adrenoceptor blocking agent and their combination on elevated blood pressure and serum potassium: a cross- over study (Q28317164) (← links)
- Low renin hypertension. A distinct entity (Q28317982) (← links)
- Effect of exercise and of prolonged oral administration of propranolol on haemodynamic variables, plasma renin concentration, plasma aldosterone and c-AMP (Q28321483) (← links)
- An opposing role for the adrenals in the hypotensive effects of propranolol in the spontaneously hypertensive rat (Q28327891) (← links)
- Renin concentrations and effects of propranolol and spironolactone in patients with hypertension (Q28328880) (← links)
- The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension (Q28329320) (← links)
- Beta-adrenergic receptor blocking drugs, hypertension and plasma renin (Q28329348) (← links)
- Plasma renin concentration in essential hypertension during beta-adrenergic blockade and vasodilator therapy (Q28333345) (← links)
- The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients (Q28334539) (← links)
- Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension (Q28336901) (← links)
- Glomerular Filtration Rate and Renal Plasma Flow in Patients with Essential Hypertension before and after Treatment with Alprenolol (Q28340768) (← links)
- Plasma renin activity in acute poststreptococcal glomerulonephritis and the haemolytic-uraemic syndrome (Q33463272) (← links)
- Exercise metabolism and beta-blocker therapy. An update (Q33544862) (← links)
- Uses of beta-adrenoceptor blocking drugs (Q33705898) (← links)
- The clinical pharmacology of beta-adrenoceptor-blocking drugs (Q33795787) (← links)
- Laboratory investigation of primary aldosteronism. (Q33868500) (← links)
- A survey of the pharmacological properties of metoprolol in animals and man (Q34007650) (← links)
- John H. Laragh, MD: clinician-scientist (Q34016361) (← links)
- Evolution of drugs that preserve renal function (Q34024129) (← links)
- Stepped care for hypertension is dead, but what will replace it? (Q34103548) (← links)
- Antihypertensive pharmacology (Q34108338) (← links)
- Plasma Renin Activity Predicts Blood Pressure Responses to -Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension (Q34138591) (← links)
- Angiotensin-converting enzyme inhibitors (Q34236623) (← links)
- Aliskiren - an alternative to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the therapy of arterial hypertension (Q34247173) (← links)
- The management of hypertension (Q34446787) (← links)
- Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat (Q34447368) (← links)
- Comparison of the effects on renin release of beta adrenergic antagonists with differing properties (Q34470907) (← links)
- Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity (Q34473162) (← links)
- Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension (Q34516455) (← links)
- Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined (Q34516475) (← links)
- The effects of beta-adrenoceptor blockade on renin, angiotensin, aldosterone and catecholamines at rest and during exercise (Q34516820) (← links)
- Acebutolol in hypertension-double-blind trial against placebo (Q34516984) (← links)
- A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension (Q34518934) (← links)
- Carvedilol prevents ovariectomy-induced myocardial contractile dysfunction in female rat (Q34544785) (← links)
- Hypertension: which beta-blocker? (Q34621061) (← links)
- Antihypertensive effect and degree of beta-adrenoceptor blockade after short-term and semi-chronic propranolol therapy (Q34621246) (← links)
- Flurbiprofen interaction with single doses of atenolol and propranolol (Q34622144) (← links)
- Exercise Training Versus Propranolol in the Treatment of the Postural Orthostatic Tachycardia Syndrome (Q34630458) (← links)
- Analysis of 100 children with severe and persistent hypertension (Q34989399) (← links)
- Lack of effect of beta-blocker on flat dose response to thiazide in hypertension: efficacy of low dose thiazide combined with beta-blocker. (Q34992925) (← links)
- Fibromuscular dysplasia: when is intervention warranted? (Q35219740) (← links)
- Adrenergic Beta-Blocking Agents (Q35249946) (← links)
- Beta-adrenergic blockade in hypertension (Q35537700) (← links)
- The essential action of propranolol in hypertension (Q35537767) (← links)
- Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure (Q35537965) (← links)
- Beta-adrenoreceptor blockade in hypertension (Q35539765) (← links)
- BW A575C, a chemically novel agent with angiotensin converting enzyme inhibitor and beta-adrenoceptor-blocking properties (Q35887503) (← links)